Goldman Sachs’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-146,219
| Closed | -$14.6K | – | 6455 |
|
|
2025
Q4 | $14.6K | Sell |
146,219
-8,922
| -6% | -$5.67K | ﹤0.01% | 6357 |
|
|
2025
Q3 | $93.8K | Sell |
155,141
-575,577
| -79% | -$271K | ﹤0.01% | 6091 |
|
|
2025
Q2 | $227K | Buy |
730,718
+414,488
| +131% | +$160K | ﹤0.01% | 5598 |
|
|
2025
Q1 | $155K | Sell |
316,230
-705,377
| -69% | -$415K | ﹤0.01% | 5692 |
|
|
2024
Q4 | $875K | Buy |
1,021,607
+203,841
| +25% | +$1.28M | ﹤0.01% | 4907 |
|
|
2024
Q3 | $6.95M | Buy |
817,766
+665,317
| +436% | +$3.92M | ﹤0.01% | 3058 |
|
|
2024
Q2 | $712K | Sell |
152,449
-562,759
| -79% | -$2.66M | ﹤0.01% | 4628 |
|
|
2024
Q1 | $4.86M | Buy |
715,208
+698,456
| +4,169% | +$3.14M | ﹤0.01% | 3115 |
|
|
2023
Q4 | $56.1K | Buy |
+16,752
| New | +$41.7K | ﹤0.01% | 5360 |
|
|
2022
Q4 | – | Sell |
-28,321
| Closed | -$26K | – | 5964 |
|
|
2022
Q3 | $26K | Buy |
28,321
+12,187
| +76% | +$14.6K | ﹤0.01% | 5887 |
|
|
2022
Q2 | $15K | Sell |
16,134
-78,530
| -83% | -$129K | ﹤0.01% | 6215 |
|
|
2022
Q1 | $200K | Buy |
94,664
+19,159
| +25% | +$51.3K | ﹤0.01% | 5884 |
|
|
2021
Q4 | $676K | Buy |
75,505
+13,415
| +22% | +$176K | ﹤0.01% | 5152 |
|
|
2021
Q3 | $1.03M | Buy |
62,090
+2,545
| +4% | +$43.9K | ﹤0.01% | 4713 |
|
|
2021
Q2 | $1.24M | Sell |
59,545
-11,113
| -16% | -$210K | ﹤0.01% | 4606 |
|
|
2021
Q1 | $1.32M | Buy |
70,658
+12,499
| +21% | +$270K | ﹤0.01% | 4390 |
|
|
2020
Q4 | $1.28M | Buy |
58,159
+45,711
| +367% | +$952K | ﹤0.01% | 4039 |
|
|
2020
Q3 | $258K | Buy |
12,448
+252
| +2% | +$6.55K | ﹤0.01% | 4807 |
|
|
2020
Q2 | $441K | Buy |
12,196
+1,441
| +13% | +$60.3K | ﹤0.01% | 4444 |
|
|
2020
Q1 | $352K | Buy |
+10,755
| New | +$435K | ﹤0.01% | 4408 |
|
|
2019
Q3 | – | Sell |
-24,654
| Closed | -$203K | – | 5151 |
|
|
2019
Q2 | $203K | Buy |
+24,654
| New | +$233K | ﹤0.01% | 4784 |
|
Goldman Sachs's APLT Position: Q1 2026 in Review
Goldman Sachs sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 146,219 shares — an estimated $14.6K sold.
Goldman Sachs first reported a position in APLT in Q2 2019 and held it in 21 quarters. The position peaked at $6.95M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Goldman Sachs reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Goldman Sachs sold 146,219 Applied Therapeutics shares in Q1 2026, an estimated $14.6K.
- Goldman Sachs first reported a position in Applied Therapeutics in Q2 2019 and held it in 21 quarters.
- Goldman Sachs's Applied Therapeutics position peaked at $6.95M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.